(Q35767480)

10 August 2017

1 reference

title

HIV revisited: the global impact of the HIV/AIDS epidemic (English)

1 reference

10 August 2017

1 reference

Amy Evans

1

1 reference

10 August 2017

Rachel Lee

2

1 reference

10 August 2017

Amy Mammen-Tobin

3

1 reference

10 August 2017

Anura Piyadigamage

4

1 reference

10 August 2017

Siobhan Shann

5

1 reference

10 August 2017

Michael Waugh

6

1 reference

10 August 2017

language of work or name

1 reference

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

149-156

1 reference

Use of laboratory tests and clinical symptoms for identification of primary HIV infection

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Sexually acquired hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Lipodystrophy syndrome in patients with HIV infection: quality of life issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

Anaphylaxis after rechallenge with abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2004.02304.X

10.1111/J.1540-9740.2004.02304.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference